L & S Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

L & S Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,690	Closed	-$580K	–	343
2017 Q4	$580K	Sell	12,690 -1,015	-7%	-$50.6K	0.09%	167
2017 Q3	$615K	Buy	+13,705	New	+$467K	0.1%	146

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

L & S Advisors's JUNO Position: Q1 2018 in Review

L & S Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 12,690 shares — an estimated $580K sold.

L & S Advisors first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $615K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

L & S Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
L & S Advisors sold 12,690 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $580K.
L & S Advisors first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
L & S Advisors's Juno Therapeutics, Inc. position peaked at $615K in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on L & S Advisors's 13F filing for Q1 2018, filed 14 May 2018.